Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol 2020; 5: 658-666.

Published: 17th November 2020

Authors: Andreson V, Gschossmann J, Layer P

Conclusion

A total of 443 patients were involved: active treatment was given for eight weeks. A composite endpoint including a 30 per cent improvement in pain relief, and relief of irritable bowel syndrome symptoms, was reached in 34 per cent of treated versus 19 per cent of control patients, P=0.0007.

Pubmed Link

You may also be interested in

Scientific Surgery

Efficacy of soluble fibre, antispasmodic drugs and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 117-131.

Authors: Black CJ, Yuan Y , Selinger CP, Camilleri CP, Quigley EMM, Moayyedi P et al.

Scientific Surgery

Efficacy of preoperative oral antibiotic prophylaxis for the prevention of surgical site infections in patients with Crohn’s Disease. A Randomized Controlled Trial. Ann Surg 2019; 269: 420-426.

Authors: Uchino M, Ikeuchi H, Bando T, Chohno T, Sasaki H, Horio Y et al.

Scientific Surgery

Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet 2017; 390: 2779-2789.

Authors: Colombel J-F, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T et al.

Scientific Surgery

A mechanistic multicentre, parallel group randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut 2016; 65: 91-99.

Authors: Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y et al.

Scientific Surgery

Randomised controlled trial of mesalazine in IBS. Gut 2016; 65: 82-90.

Authors: Giovanni B, Cremon C, Annese V, Basilisco G, Bazzoli M, et al. et al.

Scientific Surgery

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut 2014; 63: 1617-1625.

Authors: Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G et al. et al.

Scientific Surgery

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease. Gut 2013; 62: 1288–1294.

Authors: Sands BE, Katz S, Wolf DC, Feagan BG, Wang T, Gustofson LM et al. et al.

Scientific Surgery

HAnd suture versus STApling for closure of loop ileostomy (HASTA Trial): results of a multicenter randomized trial. Ann Surg 2012; 256: 828–836.

Authors: Loffler T, Rossion I, Bruckner T, Diener MK, Koch M, von Frankenberg M et al. et al.

Scientific Surgery

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011; 60: 902–914.

Authors: Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O’Keefe SJ. et al.

Scientific Surgery

Infliximab, azathioprine or combination therapy for Crohn’s Disease. N Engl J Med 2010; 362: 1383-95.

Authors: Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kombluth A, Rachmilewitz D et al. et al.

Scientific Surgery

A sprayable hydrogel adhesion barrier facilitates closure of defunctioning loop ileostomy: a randomized trial. Dis Colon Rectum 2008; 51: 956-960.

Authors: Tjandra JJ, Chan MKY.

Scientific Surgery

Long term outcomes of laparoscopic versus open ileocolic resection for Crohn’s Disease: follow-up of a prospective randomized trial Surgery 2008; 144: 622-628

Authors: Stocchi L, Milsom JW, Fazio VW